New funds to support growth of minimally invasive modular InterFuse® technology
We believe VTI’s modular technology has the potential to significantly disrupt the current spine market— Matt Kyle, CEOMINNEAPOLIS, MN, UNITED STATES, November 17, 2015 /EINPresswire.com/ -- Vertebral Technologies, Inc. (VTI), a differentiated spinal solutions company, today announced that it closed the first tranche of a $3.5 million Series B financing utilizing the EB-5 immigrant investor program. Proceeds from the funding will provide growth capital for VTI’s commercialization of its expandable, modular- interbody device suite designed to alleviate painful spine conditions.
As part of this first tranche of Series B financing, VTI will focus on expanding its manufacturing and inventory capacities concurrent with its sales team. “We believe VTI’s modular technology has the potential to significantly disrupt the current spine market,” said Matt Kyle, CEO at Vertebral Technologies, Inc. “We are excited about the opportunity that this financing gives VTI to grow market awareness and position.”
Read more by clicking below image